Gout
Opinion
A couple of little known side effects of medications
The cause of one patient’s acidosis and the correct blood pressure medication for another patient.
News from the FDA/CDC
Death data spur black-box warning for gout drug Uloric
FDA acts after postmarket trial shows higher all-cause and heart-related death when compared against allopurinol.
From the Journals
No drop in gout prevalence, but no increase either
Hyperuricemia also held steady over the last decade, as did the use of urate-lowering therapy.
Conference Coverage
Gout: new data support treat-to-target approach
CHICAGO – Failure to get serum urate under 6 mg/dL is an independent risk factor for all-cause mortality.
From the Journals
Symptomatic hyperuricemia may respond to urate-lowering therapy
Small case-control study serves as “potential rationale” for reclassifying the ACR/EULAR 2015 gout classification criteria, researchers said.
From the Journals
Genes found more important than diet in hyperuricemia
Diet plays a significantly less important role than genes in the development of the high serum urate levels that typically precede gout.
From the Journals
Allopurinol reduces risk of renal decline in gout patients
Conference Coverage
Stop treating gout and start curing it, physician urges
LAS VEGAS – Doctors are too unwilling, Dr. Brian F. Mandell says, to up-titrate medication to lower serum uric acid.
From the Journals
ICYMI: Canakinumab reduced risk of gout attacks
Previous analysis of CANTOS data showed canakinumab shortened the length of gout attacks.
From the Journals
Obstructive sleep apnea may promote gout
Sleep apnea predisposes patients for gout; BMI breakout shows strongest association in normal weight.
Conference Coverage
Ultrasound aids treat-to-target approach for gout
AMSTERDAM –